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ABSTRACT
PTHR1/SOX9 AND IDH1/IDH2 RELATIVE EXPRESSION IN PRIMARY CHONDROCYTE
AND CHONDROSARCOMA CELLS UNDER THE SYNERGISTIC INFLUENCE OF
INDUCIBLE HYPOXIA AND EXTRACELLULAR ACIDOSIS
Kostika Vangjeli
Old Dominion University, 2020
Director: Dr. Christopher Osgood

Cartilage cells (Chondrocytes) grow in rather unique environmental conditions in the
human body. Cartilage is avascular tissue and lacks innervation. Its main source of nutrients is
derived from the synovial fluid and/or perichondrium. Consequently, these cells must survive
and thrive under hypoxic and acidic stressors. Published data suggests that there are a multitude
of genes affected from either one of these two stressors or both. However, these factors are
frequently overlooked in cartilage research, and results are reported in either normoxia/pH=7.0
conditions, or they only account for one of the conditions. The scope of this study is to examine
how these stressors affect gene expression in primary chondrocytes and chondrosarcomas. In this
study, one primary chondrocyte cell line (CON5) and two chondrosarcoma grade II cell lines,
JJ012-IDH1 mutant and SW1353- IDH2 mutant, were grown in four experimental conditions:
hypoxia (5% O2), acidosis (pH=5.5), hypoxia and acidosis, and normoxia/(pH=7). Four genes of
interest were analyzed via RT-qPCR relative to the ACTB housekeeping gene: parathyroid
hormone receptor-1 (PTHR1), SRY-box transcription factor 9 (SOX9), and isocitrate
dehydrogenase 1 and 2 (IDH1/IDH2). PTHR1 and SOX9 keep chondrocytes in a proliferative
state and delay their hypertrophy. On the other hand, IDH1 and IDH2 are metabolic enzymes
that convert isocitrate to α-ketoglutarate (α-KG). Their mutant counterparts further convert α-KG
into a competitive oncometabolite D-2-Hydroxygluterate (D-2-HG). Our colorimetric assay data
suggest that D-2-HG concentration levels are 10.5-fold and 6-fold more elevated in
JJ012/SW1353 respectively than in the IDH wild type CON5. Our gene expression data indicates
that both inducible hypoxia and extracellular acidosis alter gene expression not only separately
but also when combined. This study further highlights the importance of these stressors in
cartilage biology research.
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This thesis is dedicated to those patients who have been affected by cartilage-related diseases and
especially from chondrosarcoma.
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CHAPTER 1
INTRODUCTION
1.1 Effects of Inducible Hypoxia and Extracellular Acidosis in Chondrocytes
Cartilage cells are unique compared to “traditional” cells in the human body in that they
have no direct access to a vascular bed and therefore rely on metabolic pathways to survive. As a
result, they operate in a hypoxic environment (<5% O2) marked by the expression of hypoxia
inducible factors (HIFs.) These transcriptional factors help chondrocytes adapt to hypoxia and
are known to induce parathyroid hormone-related protein (PTHrP) expression and its main
receptor and mediator parathyroid hormone receptor-1 (PTHR1) (Manisterski, 2010). Primary
chondrocytes have tightly regulated cycles of proliferation, differentiation, and hypertrophy. This
process is governed by a negative feedback loop between PTHrP and Indian hedgehog proteins
(IHH) (Fig. 1). However, when this loop is thrown off balance, it can result in an overexpression
of PTHrP, which is a hallmark of many bone cancers (Mak I.W., 2013; Johnson, 2011).
As a result of lack of oxygen, chondrocytes metabolize glucose via glycolysis. One of the
by-products of this reaction is lactate, leading to acidosis. Cancerous cells also share a similar
acidosis environment. They not only operate in hypoxic microenvironments, but often rely on
glycolytic instead of oxidative metabolism. In the 1920s, Otto Heinrich Warburg and his
colleagues observed that cancer cells uptake significantly more glucose than normal cells and
they do so anaerobically even when oxygen is present (Warburg, 1927).
1.2 IHH-PTHrP Loop – PTHR1 Gene
Parathyroid hormone (PTH) plays a crucial role in bone formation by maintaining Ca2+
homeostasis. PTH is largely produced by chief cells in response to low Ca2+ in blood, which
triggers a sequence of signals that lead to bone resorption. Parathyroid Hormone-related proteins
(PTHrP) are comparable to PTH in that they bind to similar receptors, mainly PTHR1. These
peptides are key regulators in the proliferation, differentiation, and death of many cell types. In
the case of chondrocytes, they prevent their differentiation, keeping them in a proliferative state
which results in delayed hypertrophy. The IHH-PTHrP is a negative feedback loop that keeps the
rate of chondrocyte differentiation tightly regulated (Vortkamp, 1996). The IHH proteins are
produced by chondrocytes in the postmitotic pre-hypertrophic zone (Iwasaki M, 1997). PTHrP,
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on the other hand, are produced by chondrocytes in the resting and proliferating zones. A drop in
the PTHrP levels signals the chondrocytes in the pre-hypertrophic zone to diffuse IHH in the
resting zone and produce PTHrP. However, as the PTHrP levels increase, they downregulate the
IHH, explaining their polarized expression and localization (Fig. 1).

Fig. 1. Cartilage zones in epiphysial plate of long bone with oxygen permeation levels and
(IHH/PTHrP loop). IHH protein secreting chondrocytes are found in the postmitotic prehypertrophic region. They induce PTHrP production in the Resting Zone (RZ) in response to a
reduced level of PTHrP in the pre-hypertrophic zone. PTHrP secreting chondrocytes are in the
RZ and as their levels increase, they gradually downregulate IHH expression in the RZ. In the
proliferating zone (PZ), chondrocytes develop a very distinct columnar shape and arrangement in
the direction of the bone growth. On the right, Gradient decrease of oxygen levels from the
perichondrium (5%) to the hypertrophic zone approximately (1%). Resorption/Ossification Zone,
oxygen levels gradually increase as the cartilage is calcified and replaced with bone matrix and
blood vessels penetrate the haversian system along with innervation.

PTHrP and their associated receptors are also known to be induced under hypoxic
conditions via HIF-1α and HIF-2α genes (Zhao H. L.-L., 2009; Manisterski, 2010).
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The following is the cellular cascade on the effects of PTHrP on delaying chondrocyte
differentiation. This process is regulated by the phosphorylation of SOX9:
PTHrP ↑ PTHR1 ↑
cAMP & Protein Kinase A production ↑
Phosphorylation of SOX9 transcriptional factor ↑
Inhibition of p57 (apoptotic gene) ↓
Expression of anti-apoptotic Gli3, Bcl-2 ↑
Runx2 and Runx3 (crucial genes in differentiation.) ↓
1.3 SOX9 gene
SOX 9 is a multi-functional transcriptional factor, and a chief regulator in sex
determination (Jakob, 2011). What is of interest to our study is that SOX9 is involved in
chondrogenesis and is highly expressed in chondrocytes (Asou, et al., 2006). However, this
expression is not uniform throughout the chondrogenic process. SOX9 expression is initially
required to commit undifferentiated mesenchymal stem cells to the osteochondrogenic process. It
is further required to transition those cells to condensed mesenchymal cells. At this stage, SOX9
activates SOX5 and SOX6 and their co-expression is required to commit these cells to
differentiate into chondrocytes. During the proliferation phase, SOX9 prevents the conversion of
chondrocytes into hypertrophy. As expected, SOX9 expression is nonexistent past the
hypertrophic zone (Zhao, et al., 1997).
Extensive studies in mice embryos have shown that deletion of SOX9 results in drastic
skeletal chondroplasia, where the cells did not go past the condensation phase (Akiyama, et al.,
2002). Moreover, SOX9 is part of the cascade that blocks apoptotic gene p53 and halts
chondrocytes from undergoing hypertrophy (Ikegami, et al., 2011). The rationale for picking this
gene is that PTHrP/PTHR1 is known to positively regulate SOX9 and persistent elevated levels
would keep chondrocytes in a proliferative state (Huang, et al., 2000).
1.4 IDH1 and IDH2 genes
Two metabolic genes of interest that have been reported to undergo mutations in many
cancer cells are IDH1 and IDH2. In healthy cells, isocitrate dehydrogenase (IDH) is an enzyme
involved in the conversion of isocitrate into α-ketoglutarate (α-KG) (Fig. 2). One of the
byproducts of this reaction is the conversion of NAD+ to NADPH, which among a multitude of
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other functions also plays a role in producing reactive oxygen species (ROS) in neutrophils and
reducing oxidative stress. This is a bidirectional reaction which depending on cellular needs can
result in α-KG production or consumption (Metallo, 2011). There are three known forms of IDH.
One is located strictly in mitochondria (IDH3) and is not known to undergo any clinically
relevant mutations (Bhagavan, 2011). Different from IDH1 and IDH2, IDH3 is involved in the
conversion of NAD+ to NADH.
Mutant IDH are observed in many clinical conditions. They are present in 85% of
enchondromatosis [multiple enchondromas (ENC) which are benign tumors], in 52-59% of
conventional CS, and 57% of dedifferentiated CS (Amary, et al., 2011). In the case of mutated
IDH1 and IDH2, the reaction does not end with the production of CO2 and α-KG but the latter is
further converted into D-2-hydoxygluterate (D-2-HG), which is an oncometabolite and
considered to be an α-KG antagonist (Yang, 2012).
D-2-HG has a variety of pathways that can lead to oncogenesis, but one that is of interest
is that it induces the HIF-1α by blocking the prolyl hydroxylase (PHDs) from marking HIF-1α
for degradation by the von Hippel-Lindau (VHL) proteins. PHDs are oxygen-sensing enzymes
that under normoxia can hydroxylate both HIF-1α/2α (Yong, 2018).
1.5 Chondrosarcoma Grade Characterization
Primary bone cancers are the rarest (<1%) of all bone cancers. Different from the
(secondary) metastatic bone tumors that spread from elsewhere from the body to the bones, the
primary cancers originate in the cartilage and bones themselves. Despite its rarity, as of 2019 it
was estimated that there were 3,500 new diagnoses of primary bone cancer in United States.
Nearly half (approximately 1660) of the above-stated number are expected to result in death
(American Cancer Society, 2019). Chondrosarcomas (CS) are the second most common form of
primary bone cancer with osteosarcomas topping the list (Siegel, 2018). This high-grade CS
exhibits an aggressive nature marked by resistance to radiation and chemotherapy. As a result,
the best treatment option is via surgical resection. However, low-grade CS have been
successfully treated by clearing the tumor via curettage, followed by liquid nitrogen cryotherapy,
slow thawing, and final bone grafting and fixation (Gelderbloma, 2008). CS are categorized into
three grades, which consider multiple factors (Fig. 3; Fig. 4).
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Fig. 2. The role of IDH in cancer metabolism of gliomas and AML.
Enzymes of the TCA cycle in the mitochondria and mutated IDH in the cytosol are represented.
The hypothesis of how 2HG produced by mutated IDH might act through the accumulation of
HIF1α via PHD inhibition leading to cancer development is shown schematically.
Abbreviations: FH-fumarate hydratase; SDH-succinate dehydrogenase; PHD-prolyl hydroxylase;
GLS-glutaminase; GDH-glutamate dehydrogenase; G6P- glucose 6-phosphate. The
IDH1/IDH2/IDH3 is a bidirectional synthesis of α-KG and isocitrate (not shown in picture).
IDH1 mutant pathway plays a pivotal role in further converting α-KG into D-2-HG. Notice the
difference in structure between the two compounds is the sole replacement of a single oxygen in
α-KG on the second carbon with a hydroxyl group which gives rise to D-2-HG.
*The above picture has been properly cited and re-printed with the author’s written permission.
(Dang, 2010)

*Enchondroma – (ENC) benign cartilage forming tumor
*Chondrosarcoma – (CS) malignant cartilage forming tumors tumor
*Primary or Conventional Chondrosarcoma – (CCS) arise in pre-existing normal bone and are common
*Non-Conventional Chondrosarcoma – include dedifferentiated CS, clear cell CS and Mesenchymal CS: less common
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Fig. 3. Chondrosarcoma grade classification. Multiple criteria are taken in consideration when
determining the grade classification of chondrosarcoma. Cellularity increases from lower grade
to higher ones. Chondroid matrix decreases. Myxoid matrix becomes present in grade II
chondrosarcoma and more pronounced in grade III but is missing in grade I. Nuclear atypia is
increasingly more observable as we move from grade I-III. Cellular spindling, mitosis and
necrosis are observable mostly in grade II and III and absent in grade I.
Copyright © 2010 Kim, Cho, Ayala, and Ro. This is an open access article (picture) distributed
under the Creative Commons Attribution License, which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited. * (Kim et al.,
2010)

Note the degree of cellularity with the tumor grade progression (Fig. 3). Hyaline cartilage
is hypocellular exhibiting low cellularity. Chondroid matrix is abundantly being secreted. As the
tumor progresses from grade I-III the amount of chondroid matrix decreases while cellularity
increases. The nature of ECM changes with the grade progression. In grade II and higher, it
consists of part-hyaline chondroid cartilage, part-myxoid. Myxoid cartilage is defined as when
the chondrocytes no longer reside in lacunae spaces and develop cytoplasmic processes. In
addition, mitotic activity is mainly absent in ENC and low-grade CS. It progressively becomes
more present and hypercellular in grades II and III. Nuclear atypia strictly refers to the size of
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cell nucleus. Grade I chondrosarcoma cells have nuclei that are 2-3 times larger than those of
normal chondrocytes. With grade progression those differences become even more pronounced.
In grade II and III, cells take a stellate shape like extensions, and irregular contours are also
present as we progress to higher grade levels.

Fig. 4. Grade II chondrosarcoma in tissue (H&E staining). Several features of chondrosarcoma
are present that set them apart from enchondromas. Increased cellularity; myxoid change in the
matrix; and most importantly the invasive nature of cartilage growth around pre-existing
trabecular bone.
Copyright © 2010 Kim et al. This is an open access article (picture) distributed under the
Creative Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. (Kim, et al., 2010)

One can observe the degree of cartilage infiltration (blue) into pre-existing bone
trabeculae (red) in Fig. 4. This is one of the most distinct characteristics that differentiates any
grade CS from ENC. In aggressive tumors, the rate of tumor growth is faster than the rate of
osteoclasts being able to form and resorb bone. Thus, one can observe the infiltration pattern as
depicted in Fig. 4. Benign slow growing tumors, such as ENC grow in nodules that are well
contoured and delineated by bone tissue. In such cases the tumor growth is slower than the rate
of osteoclasts being able to absorb bone. Cartilage growth will be well defined and lack
infiltration characteristics, hence explaining the growth pattern.
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Lastly cartilage tumors have the ability to “scallop” (not shown in picture). Cartilage
nodules will impinge the inner layer of the circumferential lamellae of the bone cortex. This
results in osteoclast resorption. Once the cortex has been pierced, the tumor can metastasize
elsewhere in the body.
1.6 Significance and Hypotheses
Since the cartilage milieu is one of hypoxia and acidosis, it stands to reason you should
minimize confounding factors that can significantly alter data interpretation and conclusions.
This can be achieved by using hypoxic/acidic fixed media that mimics the chondrocyte’s
naturally occurring environment. However, there is a paucity of research analyzing the
synergistic effect that both these stressors have on relative gene expression or cell-to-cell
communication. Often, results are reported under normoxia/pH=7.0 media conditions.
Considering the significance of hypoxia and acidosis in cartilage biology, any study that analyzes
the HIF group of proteins and its effect on downstream targets (PTHRrP/PTHR1/SOX9 among
them), must take in account the above stated facts in experimental design. Of note, in ambient
conditions of 21% O2, the half-life of HIF-1α is less than 5 minutes and it is marked for rapid
degradation (Elkins, 2002).
IDH1/IDH2 mutants in CS are the most likely contributors to further induce HIF-1α and
prevent them from being marked for proteasomal degradation. Consequently, PTHR1 and SOX9
will also be upregulated, keeping cells in a proliferative state and delaying their eventual
hypertrophy. In order to elucidate the above-mentioned relationships, we analyze the relative
gene expression of four genes of interest: PTHR1, SOX9, IDH1, and IDH2 in reference to the
actin beta (ACTB) housekeeping gene in all four conditions: hypoxia/acidosis, hypoxia only,
acidosis only, and normoxia/pH=7.0. Both 18SrRNA and GAPDH were excluded as possible
housekeeping candidates due to their active role in hypoxia. We hypothesize that IDH1/IDH2
will be more upregulated in CS, specifically IDH1 in JJ012 and IDH2 in SW1353 in
comparison to IDH expression in primary chondrocyte (CON5). Moreover, combined
hypoxia/acidosis positively upregulates expression of PTHR1 compared to both stressors
alone in primary chondrocytes (CON5), and expression is further exacerbated in
chondrosarcoma grade II: JJ012 (IDH1 mutant) and SW1353 (IDH2 mutant).
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CHAPTER 2
MATERIALS AND METHODS
Work undertaken for this thesis was approved by ODU Institutional Biosafety Committee #1182126.4.

2.1 Cell Culturing
JJ012 cells were kindly donated by Dr. J Block (Rush University Medical Center,
Chicago, IL USA).
Newly thawed SW1353 and JJ012 cells were plated in T75 flasks with Dulbecco’s
modified eagle medium (DMEM); 10% chondrocyte growth supplement and 1% streptomycin.
Once the cells reached 80-90% confluency, they were trypsinized, resuspended in
normoxia/pH=7 DMEM, and 0.5ml of the cell suspension (approximately 1x106 cells) was
plated in 4.5ml of normoxia/pH=7 DMEM in a T25 flask. The same process was repeated for
three additional experimental conditions: normoxia/pH=5.5 (acidosis); hypoxia/pH=7 and
hypoxia/pH=5.5. The normoxia-treated flasks were incubated at 37ºC in humidified 5% CO2 and
20% O2 for 48 hours. The hypoxic-treated flasks were incubated at 37ºC in humidified 5% CO2
and 5% O2 (balanced with 90% N2) for 48 hours. In order to equilibrate the oxygen tension, all
media used for hypoxic treatments were de-gassed 48 hours prior to plating by keeping the
media in the hypoxic induced chamber. Moreover, the T25 empty flasks were de-gassed one
hour before plating the cells. The media was adjusted to acidic level of pH=5.5 by adding 1M
HCl solution in the DMEM and measured by the AB15 pH meter probe (Thermo Fisher
Scientific).
2.2 RNA Extraction and cDNA Synthesis
After 48 hours, the JJ012 cells were lysed inside the flasks by adding 350μL Trizol and
left at room temperature for 10 minutes. An equal volume of 99.5% ethanol was added to the
lysate. The RNA extraction for SW1353 was completed using ISOLATE II RNA MiniKit
(Bioline, Swedesboro, New Jersey. Cat No. BIO-52071) following the manufacturer’s
guidelines. The RNA concentration for both cell lines was measured using Nanovue Plus
Nanodrop (GE Healthcare, Little Chalfont, UK). cDNA synthesis was achieved using
SensiFASTTM cDNA Synthesis Kit (Bioline, Swedesboro, New Jersey. cat. No.BIO-65053)
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following the manufacturer’s recommended steps. cDNA concentration was measured using the
Nanovue Plus Nanodrop.
2.3 RT-qPCR
RT-qPCR was performed to measure the relative fold expression of each gene for each
cell line. The PCR Mastermix (PM) was prepared first by adding 12.5μL SYBR Green
Mastermix multiplied by the number of wells needed. Next, 10.5μL nuclease-free grade water
was added multiplied by the number of wells needed. Each well contained the following
components: 23μl of PM; 1μl of the appropriate primer and 1μl of cDNA for each of the
assigned conditions. In total, each well contained 25μl of solution and was run in triplicates for
each treatment. Additionally, each primer had its own quality control (QC) well that received
23μl PM; 1μl primer and 1μl nuclease-free water for a total of 25μl.
Primers used:
RT2 PCR Primer Set for Human PTH1R (NM_000316). RT² qPCR Primer Assay (Qiagen,
PPH00740A-200)
RT² qPCR Primer Assay for Human SOX9 (NM_000346). RT² qPCR Primer Assay (Qiagen,
PPH02125A-200)
RT² qPCR Primer Assay for Human IDH1 (NM_005896). RT² qPCR Primer Assay (Qiagen,
PPH06067A-200)
RT² qPCR Primer Assay for Human IDH2 (NM_002168). RT² qPCR Primer Assay (Qiagen,
PPH07326A-200)
RT² qPCR Primer Assay for Human ACTB (NM_001101). RT² qPCR Primer Assay (Qiagen,
PPH00073G-200)
2.4 Data Analysis
Relative gene expression for PTHR1, SOX9, IDH1 and IDH2 were measured relative to
the ACTB housekeeping gene expression. Cq values were generated in the RT-qPCR for each
gene for all four treatments: hypoxia/acidosis, hypoxia only, acidosis only, and normoxia/pH=7.
Since there were a minimum of three data points for each experiment, the standard error of mean
was calculated for each Cq value, which was negligible. Next, ΔΔCq values were calculated for
each gene of interest in relation to ACTB. The fold expression values were normalized in log2 in
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relation to their respective gene expression in normoxia/pH=7 to determine which genes were
up- and down-regulated.
A two-way analysis of variance ANOVA (nonparametric) was conducted for each gene
followed up by Bonferroni post-test to pinpoint the source of variance between the treatments
within each cell line. For D-2-Hydoxygluterate data, a one-way ANOVA (nonparametric) was
applied followed by Tukey’s test. The significance value was set at p<0.05. GraphPad Prism
software was used to generate the graphs with built-in mean and standard error of mean (SEM).
2.5 Cell Proliferation Assay
In order to further elucidate the differences between the JJ012/SW1353 and the primary
chondrocyte CON5, 104 cells were initially plated for each cell line in every individual well of a
6-well plate on three different plates. Each well was assigned a specific day 1-5. The wells
labeled as “day 1” were washed with PBS and trypsinized after 24 hours. The cells were
centrifuged, resuspended in 1ml of DMEM, and counted using a hemocytometer for each cell
line. After 48 hours the wells labeled as “day 2” underwent the same process. This procedure
was repeated up to day 5. Data for the growth curve was plugged in Prism to generate a graph
with all three cell lines including their doubling rate.
2.6 D-2-Hydroxyglutarate Assay (Colorimetric)
D-2-hydroxygluterate concentration levels in SW1353, JJ012, and CON5 cell lysate were
measured by using a colorimetric assay kit (ab211070) according to manufacturer’s
recommendations (Abclonal). The IDH1/IDH2 mutants in JJ012 and SW1353 were indirectly
confirmed due to elevated D-2-HG elevated concentration levels when compared to the IDH
wild type CON5. In primary chondrocytes, D-2HG levels are minimal. The cell lysates were
derived by cultures that were grown in normoxia/pH=7.
2.7 Puromycin Selection and Lentiviral Transfection
The lentiviral clone, CAG-GFP lentivirus, was used to transfect JJ012 and SW1353 cells.
One of the genes included in the vector is PuroR, which confers puromycin resistance to the cells
once they have been successfully transfected. The minimum puromycin level needed to kill each
cell line was determined prior to transfection. Cancer cells respond differently to puromycin
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selection, with reports from 200-400ng/ml in fibrosarcoma (Zhong, 2007) to as high as
5000ng/ml in human breast cancer cells (Johnstone, 2008). To our knowledge, no published
report exists on the puromycin concentration needed for chondrosarcoma cells (Thermo Fisher
Scientific, 2019). Following manufacturer’s recommendations, serial dilutions were performed to
determine the optimal puromycin concentration for JJ012 and SW1353 chondrosarcoma cells. In
each well, 160,000 cells were plated in a 96-well plate in triplicates for each dilution and each
separate chondrosarcoma cell line. Then, 120μl of Dulbecco’s modified eagle medium (DMEM)
with 10% chondrocyte growth supplement and no antibiotic were added to each well. The plate
was incubated overnight at 37ºC at 5% CO2 and 20% O2. The puromycin stock, 10mg/ml in
distilled water, sterile filtered (alfa aesar by Thermo Fisher Scientific, J67236) was serially
diluted in increments of 1000ng/ml from 10,000ng/ml to 1000ng/ml. The following day, the
media was aspirated and replaced with 120μl per well of the puromycin-rich DMEM at the
appropriate concentrations. The plate was incubated at 37ºC at 5% CO2 and 20% O2. Results
were observed and photographs captured using BX-51 phase contrast microscope at the two-day
mark and at the four-day mark with the media replenished on the second day (data not included).
In the end of the fourth day, cell death was observed in all concentrations except the control cells
with no puromycin. This was an indicator that the minimum puromycin concentration needed
was at sub 1000ng/ml. In order to obtain precise results, the titration was repeated with finer
increments of 100ng/ml ranging from 1000ng/ml to 100ng/ml and control cells with no antibiotic
added. Pictures were taken using phase contrast BX-51 microscope at the two- and four-day
marks. Based on those results, it was determined that the minimum concentrations of puromycin
that result in complete cell death for JJ012 and SW1353 are 400ng/ml and 500ng/ml respectively
(Fig. 5).
Once the minimum puromycin concentration was determined for SW1353 and JJ012, the
cells were transfected with the lentiviral clone, CAG-GFP (Cellomics Technology, Halethorpe,
MD). On day 1, 104 cells per well were plated on DMEM with 10% growth factors and 1%
penicillin/streptomycin in a 24-well plate. Four rows (2 wells per row) were plated representing
four distinct multiplicities of infection (MOI=10,5,1 and 0). On day 2, the transduction media
was prepared at the right dilution for each MOI. Polybrene was used to increase the efficacy of
the viral infection. However, since it can be toxic for the cells, it was diluted from its original
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concentration of 10mg/ml (10μg/μl) to 5.0μg/μl in up to 5ml of growth media (0.5ml/well x 10
wells.) The formula used to calculate the amount of lentivirus needed/MOI was:
Total transducing unit (TU) needed = number cells/well x desired MOI
Total volume of lentivirus = TU/ (108 TU/ml constant value)
MOI=10; (2 wells x 104 cells x 10)/108= 0.002ml (2.0μl) lentivirus/well (4 μl lentivirus in
1ml polybrene media for 2 wells)
MOI= 5; (2 wells x 104 cells x 5)/108= 0.001ml (1.0μl) lentivirus/well (2 μl lentivirus in
1ml polybrene media for 2 wells)
MOI=1; (2 wells x 104 cells x 1)/108= 0.0002ml (0.2μl) lentivirus/well (0.4 μl lentivirus
in 1 ml polybrene media for 2 wells)
The plate was centrifuged at 800g for 30 minutes and incubated at 37ºC at 5% CO2. On
day 3, the media was aspired from the wells and new media with no antibiotic was added to
allow enough time for the expression of the puromycin-resistant gene. On day 5, the media was
aspirated, and puromycin-rich media was introduced at the appropriate determined
concentrations for JJ012 and SW1353. Then the cells were checked for survivability. All cells
under MOI 10, 5 and 1 survived and expressed GFP, indicating a successful transfection, while
the control cells without the antibiotic-resistant gene died after the second round of treatment
with the puromycin-rich media. Images of the successful transfection of the cells were captured
using a BX-51 phase contrast microscope in Fig. 10. Cells from MOI 10, 5, and 1 were pooled
together and plated in a T-25 flask for each cell line. Cells were kept under puromycin selection
for approximately one month, then they were frozen at -80ºC for 24 hours in DMSO, followed
by further freezing and storage in liquid nitrogen at -196ºC.
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Fig. 5. Puromycin selection for JJ012 (row A/C) and SW1353 (row B/D).
Cells were evaluated every two days and the minimum puromycin concentration that resulted in
complete cell death after 4 days was the concentration used for the lentiviral experiment. Based
on the phase contrast images at 10X magnification, complete cell death for JJ012 was observed
at 400ng/ml (0.4μg/ml). This is marked with distinctly darker and shrinking cells as opposed to
healthy-looking ones, which appear bright from the inside. See higher concentrations for a
comparison basis. Using the same parameter, for SW1353 the lowest concentration under which
complete cell death was observed was at 500ng/ml (0.5μg/ml).
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CHAPTER 3
RESULTS
3.1 RT-qPCR Cycles, Melt Curves and Melt Peaks
Denaturation is the first step in the PCR reaction. The thermocycler in the CFX Connect
Real-Time System (BIO-RAD; Hercules, CA) reaches approximately 95ºC, which causes the
double stranded DNA helix to unwind into two, single stranded (ssDNA) chains. This phase lasts
for 10 minutes. During the annealing phase, the temperature drops to 60ºC which allows the
primers to attach to the appropriate end of the target sequence for the next minute. At the onset
of the extension phase (5 seconds), the temperature slightly increases from 60ºC to 65ºC. DNA
polymerase attaches to the primers and allows the addition of nucleotides which are
complementary to the DNA template. This results in extended double stranded DNA (dsDNA).
SYBR Green binds to the newly synthesized DNA and fluoresces as the reaction progresses. The
fluorescence accumulates and is measured after each cycle. The Cq value measured represents
the intensity of the fluorescence above the background level. The above steps were repeated for
40 cycles, followed by melt curve analysis from 65ºC to 95ºC in 0.2ºC increments to ensure melt
point temperature consistency in each primer set (Fig. 6; Fig. 7).

Fig. 6. RT-qPCR amplification (CON5). SYBR green value amplification in Relative
fluorescence units (RFU) in relation to how many cycles are needed for each primer set to
generate a signal in primary chondrocyte cells (CON5) The same steps were followed for the two
CS: JJ012 and SW1353 to generate Cq values.
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Fig. 7. RT-qPCR Melt Curve and Melt Peak (CON5). Each prominent spike represents melting
peaks of a given gene: To ensure that the primers melting peak was consistent the temperature
range was determined along with the standard deviation (SD) and Standard error of mean (SEM):
SOX9 – 85.6°- 85.8° (SD=0.1/ SEM = 0.029); ACTB – 84.8° - 85.0° (SD=0.16 / SEM =0.04);
PTHR1 – 82.6° - 83° (SD=0.13 / SEM=0.04); IDH1- 77.2°- 77.8° (SD=0.21 / SEM=0.06); IDH2
– 82.0° - 82.2° (SD=0.09 / SEM=0.028)

Cq values were generated at the end of each RT-qPCR experiment.
Relative fold expression ΔΔCq = 2-(Gene of interest Cq -ACTB Cq) was calculated for all 4 experimental
conditions: hypoxia/acidosis; hypoxia/pH=7; normoxia/pH=5.5; normoxia/pH=7.
The ratio value was calculated in relation to our experimental control normoxia/pH=7 and the
value normalized on log2: ΔΔCq (experimental condition) / ΔΔCq (Control normoxia/pH=7)

3.2 Aggressive Growth of JJ012 vs SW1353 and CON5

Fig. 8. Cell proliferation linear and log graph. JJ012 grade II chondrosarcoma cell line displays a
rather aggressive growth pattern (exponential). Doubling time was approximately 23-24 hours (1
day). In contrast, the same grade chondrosarcoma SW1353 is comparatively identical to the
primary chondrocyte CON5 cell line. For both cell lines, the doubling time is approximately 4648 hours (2 days).
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SW1353 and JJ012 are both classified as primary human chondrosarcoma grade II even
though they exhibit distinct morphological features. Not to be confused with tumor stage, the
tumor grade takes into consideration the cell’s abnormality and its pleomorphic qualities under a
microscope. Stage tumor defines the metastatic ability of these tumors to spread elsewhere in the
body. In our case, the grade of these cell lines was easily traceable, but not the stage due to
confidential patient information and IRB guidelines.

Fig. 9. SW1353/CON5/JJ012 phenotypical profile. The enlarged nuclei can be observed in JJ012
and SW1353. In addition, there are mitotic figures present in both cell lines. Due to their
aggressive nature, JJ012 can be more closely associated with dedifferentiated chondrosarcoma
than conventional grade II CS. As a reference point, CON5 provides distinct morphological
differences with hypo chromatic nuclei that are 2-3 times smaller than those of CS.

Fig. 10. Chondrosarcoma-CAG-GFP lentivirus clone transfection. Successful viral transfection
was confirmed by the survival of SW1353/JJ012 under puromycin selection as well as
expression of GFP under BX-51 phase contrast microscope FITC setting. JJ012 showing clear
distinct atypia and increased nucleus size. SW1353 phenotypically are closer to primary
chondrocytes.

18

The JJ012 cell line was obtained from a 39-year-old male. Its aggressive nature can be
highlighted by the fact that it has a doubling time of approximately 24 hours (Fig. 8). They are
mainly polyhedral in shape, contain enlarged hyperchromatic nuclei, and are often binucleated.
Mitotic figures are common, and there is distinct cell atypia and pleomorphism (Fig. 9). They
have developed eosinophilic cytoplasmic extensions since most of their metabolism is directed
not at producing extra cellular matrix (ECM), but multiplying (Fig. 9; Fig. 10). This has led some
researchers to treat this cell line as more closely related to dedifferentiated chondrosarcoma
(Nakagawa, et al., 2019). On the other hand, SW1353 originated from the right humerus of a 72year-old female in 1977. In appearance and doubling time, they resemble CON5 cells. Unlike
CON5, SW1353 exhibit moderate cell atypia and pleomorphic characteristics. Lastly, the CON5
primary cells were isolated from a healthy 25-year-old female. Size of the cell nuclei are
considerably smaller than those of SW1353 and JJ012, and there is a lack of mitotic activity and
cellular atypia.
3.3 Hypoxia/acidosis PTHR1 upregulation in CON5

Fig. 11. PTHR1 relative gene expression. The log2 fold change in PTHR1 expression is shown
for each cell line in all three conditions: hypoxia/acidosis, hypoxia, and acidosis. Since the
relative fold change was normalized in log2, positive values represent upregulation from the
control condition in normoxia/pH=7, while negative values show downregulation from the
control. Due to that data transformation, gene expression values between 0-1 in either direction
are described as marginally/slightly downregulated or upregulated depending on the direction.
Whereas, expression values greater or smaller than 1 are described as significantly upregulated
or downregulated from the control.
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There is a difference in PTHR1 expression between the cell lines in each condition: In
hypoxia /acidosis, CON5 and SW1353 are significantly upregulated (2.10 ± 0.835 SEM and 1.77
± 0.37 SEM respectively). JJ012 is slightly downregulated (-0.33 ± 0.08 SEM). This expression
is significantly different: JJ012 versus CON5 p<0.001 and JJ012 versus SW1353 p<0.01).
In hypoxia only, SW1353 is slightly downregulated (-0.18 ± 0.2533 SEM); JJ012
upregulated (+1.85 ± 0.31) and CON5 is upregulated (1.29 ± 0.04). This expression between cell
lines is significant: JJ012 versus SW1353 (p<0.001) and CON5 versus SW1353 (p<0.05). (Table
1).
Lastly, when acidosis is the only stressor, CON5 and SW1353 are slightly upregulated
(0.84±0.03 SEM and 1.00±0.31 SEM respectively) while JJ012 is downregulated (-1.04±0.12
SEM). The difference in expression is significant (p<0.01 for both cell lines) when compared to
JJ012 (Table 1). Overall, PTHR1 was upregulated in all conditions in the primary chondrocyte,
with the largest expression in the combined conditions. Hypoxia had an upregulating effect on
JJ012, while acidosis induced downregulation. Their synergistic effect was one of marginal
downregulation. These stressors had opposite effects on SW1353 and resulted in significant
upregulation in combined conditions in Fig. 11.

3.4 Acidosis dependent upregulation of SOX9 in CON5

Fig. 12. SOX9 relative gene expression. The log2 relative fold change in SOX9 expression is
shown for each cell line in all three conditions: Hypoxia/acidosis, hypoxia, and acidosis. The
most notably significant difference is the acidosis dependent (>2.0 log fold change) upregulation
of SOX9 expression in CON5 cells, and largely independent relationship from hypoxia condition.
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There is a difference of SOX9 expression between the cell lines in each condition: In
hypoxia /acidosis, primary chondrocyte is significantly upregulated (2.36 ± 0.085 SEM) and that
expression is significant when compared to JJ012 and SW1353 (p<0.001 for both) (Table 2).
Moreover, SW1353 shows negligible difference from normoxia/pH=7 with (0.05±0.16 SEM) log
fold upregulation, while JJ012 is downregulated (-0.84±0.06 SEM) (Fig. 2).
Hypoxia alone, induces marginal SOX9 expression in JJ012 (0.44±0.20 SEM) and
downregulates it in the other two cell lines: (-0.75±0.19 SEM) in SW1353 and (-0.74±0.0889
SEM) in CON5. Moreover, the difference in expression between cells is significant (JJ012 vs
SW1353 p<0.01; JJ012 vs CON5 p<0.001) (Table 2).
In acidosis only, SOX9 expression in primary chondrocyte is similarly over expressed
(2.60 ± 0.90 SEM) log fold change just like in the combined condition. In the other two
chondrosarcomas that expression shows marginal variation from the base. In JJ012, SOX9
expression is slightly downregulated (-0.11±0.39 SEM) and in SW1353 slightly upregulated
(0.55 ±0.035 SEM). The expression is significantly different between cells: (CON5 vs JJ012
p<0.001; CON5 vs SW1353 p<0.001) (Table 12).

3.5 IDH1 unaffected by hypoxia/acidosis in SW1353/CON5 and sensitive to both hypoxia
and acidosis in JJ012

Fig. 13. IDH1 relative gene expression. The log2 fold change in IDH1 expression is shown for
each cell line in all three conditions: Hypoxia/acidosis, hypoxia, and acidosis. Notice the
negligible change of expression in SW1353 and CON5 from the control in all conditions. JJ012
is an IDH1 mutant, while CON5 is an IDH wild type.
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In the combined conditions of hypoxia/acidosis, IDH1 expression in SW1353 was
slightly downregulated (-0.15 ± 0.2025 SEM); in JJ012 it was upregulated (1.19 ± 0.31 SEM)
and in CON5 it showed slight upregulation (0.14 ± 0.2255). This expression was significantly
different between JJ012 and SW1353 (p<0.001) as well as between JJ012 and CON5 (p<0.01).
Under the effects of hypoxia alone, IDH1 expression in SW1353 was marginally
upregulated from the control (0.04 ± 0.1015 SEM); in JJ012, it was slightly more upregulated
(0.50 ±0.18 SEM) and in CON5, it was slightly downregulated (-0.15 ± 0.0441 SEM). There was
no statistically significant difference of IDH1 expression between the cells in hypoxia alone.
Lastly, when acidosis is the only stressor, IDH1 expression in SW1353 was slightly
upregulated (0.37 ± 0.1572 SEM); in JJ012, it was downregulated (-0.83 ± 0.29 SEM) and in
CON5, it was minimally downregulated (-0.07 ± 0.0808 SEM). There is a significant difference
in expression between JJ012 since it was downregulated more than the other cell lines. JJ012
versus SW133 (p<0.001) and JJ012 versus CON5 (p<0.05).
Overall, in SW1353 and CON5 there was a minimal up/down regulation of IDH1
expression across all three experimental conditions from the control (normoxia/pH=7).

3.6 Acidosis driven IDH2 expression in SW1353/CON5 and upregulated synergistic effect
in JJ012

Fig. 14. IDH2 relative gene expression. The log2 fold change in IDH2 expression is shown for
each cell line in all three conditions: Hypoxia/acidosis, hypoxia, acidosis. Notice the consistent
and significant upregulation of all three cell lines under acidosis alone.
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IDH2 expression in all three cell lines is upregulated under the combined conditions:
SW1353 (0.85 ± 0.1530 SEM); JJ012 (1.54 ± 0.19 SEM) and CON5 (2.10 ± 0.835 SEM). There
is no statistically significant difference in IDH2 expression between the cells.
Hypoxia alone, upregulates IDH2 expression in JJ012 (1.36 ± 0.42) while it
downregulates it in CON5 (-0.46 ± 0.0781 SEM) and slightly upregulates it in SW1353 (0.22 ±
0.1172 SEM). The expression is significantly different between JJ012 and SW1353 (p<0.01) as
well as between JJ012 and CON5 (p<0.001).
Lastly, when acidosis is the only stressor, the IDH2 expression is upregulated in all cells :
SW1353 (1.58 ± 0.1495 SEM); JJ012 (1.47 ± 0.28 SEM) and CON5 (2.02 ± 0.0984 SEM). The
upregulation was similar in all three cell lines therefore there was no statistically significant
difference in IDH2 expression.

3.7 D-2-Hydroxygluterate elevated concentration levels in Chondrosarcoma

Fig. 15. D-2-Hydroxygluterate concentration levels. There is a significant increased
concentration of D-2-HG in JJ012 (621.9 nmol/µl) and SW1353 (361.6 nmol/µl) in comparison
to CON5 (59.6 nmol/µl). The cell lysate from where the D-2-HG concentration was measured
was harvested in cultures grown in normoxia/pH=7.

D-2-HG is an oncometabolite and is highly produced in cells that harbor IDH1/IDH2
mutations. IDH wildtype will convert isocitrate into α-ketoglutarate, therefore D-2-HG levels
should be minimal. The difference between α-ketoglutarate and D-2-HG consist of a single
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replacement of an oxygen atom with a hydroxyl group. D-2-HG was the most elevated in JJ012,
followed by SW1353 and lowest in CON5 (Fig. 15). There is a significant difference in
concentration level between the cell lines: (JJ012 vs CON5 p<0.001); SW1353 vs CON5 p<0.01
and JJ012 vs SW1353 p<0.01) (Table 5).

3.8 Statistical Analysis
Table 1
PTHR1 two-way ANOVA. Statistical analysis of PTHR1 expression followed by Bonferroni
post-test to compare replicate means by row (the source of variance of ANOVA between cell
lines compared to each other). The (p) value interpretation: ns (not significant); * (p<0.05);
** (p<0.01); *** (p<0.001).
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For PTHR1 expression, Bonferroni posttest shows a significant row factor relationship
between SW1353 and JJ012 in the combined conditions (p<0.01), in hypoxia (p<0.001), in
acidosis (p<0.01). Between SW1353 and CON5 there is no significant difference in the
combined conditions (p>0.05) and acidosis (p>0.05). However, in hypoxia the difference is
significant (p<0.05). Between JJ012 and CON5, there is a significant difference in PTHR1
expression in the combined conditions (p<0.001), and in acidosis only (p<0.01). While no
difference was observed due to hypoxia alone (p>0.05).

Table 2
SOX9 two-way ANOVA. Statistical analysis of SOX9 expression followed by Bonferroni posttest to compare replicate means by row (the source of variance of ANOVA between cell lines
compared to each other). The (p) value interpretation: ns (not significant); * (p<0.05);
** (p<0.01); *** (p<0.001).
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For SOX9 expression, Bonferroni posttest shows a row factor relationship between
SW1353 and JJ012 in the combined conditions (p<0.05) and hypoxia (p<0.01). While no
significant difference is observed under acidosis (p>0.05). Between SW1353 and CON5 there is
no significant difference of SOX9 expression in hypoxia. However, in combined conditions and
acidosis the difference is significant (p<0.001). Between JJ012 and CON5, there is a significant
difference in all three conditions (p<0.001).

Table 3
IDH1 two-way ANOVA. Statistical analysis of IDH1 expression followed by Bonferroni posttest to compare replicate means by row (the source of variance of ANOVA between cell lines
compared to each other).
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For IDH1 expression, Bonferroni posttest shows a row factor relationship between
SW1353 and JJ012 in the combined conditions (p<0.001) and acidosis (p<0.001). While no
significant difference is observed under hypoxia (p>0.05). Between SW1353 and CON5 there is
no significant difference of IDH1 expression in any of the conditions (p>0.05). Between JJ012
and CON5, there is a significant difference in the combined conditions (p<0.01) and acidosis
(p<0.05). While no significant expression was observed under hypoxia (p>0.05).

Table 4
IDH2 two-way ANOVA. Statistical analysis of IDH2 expression followed by Bonferroni posttest to compare replicate means by row (the source of variance of ANOVA between cell lines
compared to each other).
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For IDH2 expression, Bonferroni posttest shows a row factor relationship between
SW1353 and JJ012 in hypoxia (p<0.01). While no significant difference is observed under
combined conditions and acidosis only (p>0.05). Between SW1353 and CON5 there is no
significant difference of IDH2 expression in any of the conditions (p>0.05). Between JJ012 and
CON5, there is a significant difference in hypoxia (p<0.001) but not in acidosis and combined
conditions (p<0.05).

Table 5
One-way ANOVA (nonparametric) and Tukey’s comparison test. The one-way ANOVA and
Tukey’s Multiple Comparison Test established the statistical difference between D-2-HG
concentration levels between each cell line.

One-way ANOVA and Tukey’s posttest established a significant difference in D-2-HG
concentration levels between JJ012 and SW1353 (p<0.01). The difference between SW1353 and
CON5 was also significant (p<0.01). The most pronounced significance was observed between
JJ012 and CON5 (p<0.001). Indeed, the D-2-HG level in JJ012 was 10.5-fold higher than that in
CON5.
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Table 6
Basic statistics on gene expression. The Mean and Standard Error of Mean (SEM) was calculated
for each gene and cell line under combined conditions, hypoxia only and acidosis only.
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CHAPTER 4
DISCUSSION
To interpret which stressor has the most significant influence on gene expression for a
given cell line, they are first evaluated separately. If one downregulates expression while the
other upregulates it, the stressor that has the most significant effect is the one that matches with
the direction of the combined effect.
PTHR1 – The two main objectives of analyzing PTHR1 were to observe whether the
PTHrP-IHH pathway is involved or disrupted in any way to the point where it creates a cascade
of effects leading to carcinogenesis. If PTHR1 is significantly upregulated in chondrosarcoma
and downregulated in the primary chondrocyte, that would be an indicator that cells are
remaining in a proliferative state rather undergoing hypertrophy. The second objective was to
establish that hypoxia does induce PTHR1 expression and can become a confounding factor if
overlooked. Our results indicate that in the combined condition, PTHR1 is most upregulated in
CON5 when compared to JJ012 (p<0.001) and SW1353 (Table 1). Not only that, but PTHR1
expression remains upregulated in all three experimental conditions in the primary chondrocyte:
hypoxia/acidosis (2.10± 0.835 SEM); hypoxia (1.29 ± 0.04) and acidosis (0.84 ± 0.03).
In JJ012, PTHR1 upregulated expression is sensitive to hypoxia since it is the only
condition under which it is significantly upregulated by (1.85 ± 0.31 SEM) log fold change.
Under acidic conditions, it was downregulated (-1.04 ± 0.12). Their cumulative effect resulted in
marginal downregulation from control (-0.33 ± 0.08).
In SW1353, the PTHR1 upregulation was mainly driven by acidosis (1 ± 0.3117 SEM)
since in hypoxia it was marginally downregulated (-0.18 ± 0.2533 SEM) and their combined
effects resulted in upregulation (1.77 ± 0.37 SEM).
Our results show that the relative gene expression was not as elevated in chondrosarcoma
as in the primary chondrocyte. However, the PTHrP-IHH loop pathway should not be ruled out.
We have taken in consideration only half of the loop. Indeed, there is evidence that points to
Indian hedgehog proteins as the culprit. Tiet, et al. (2006) suggests that in enchondromas and
chondrosarcomas, the PTHrP-IHH pathway is largely missing. After treating normal growth
plates with PTHrP, the IHH levels were downregulated as expected. However, when the same
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treatment was applied to enchondroma and chondrosarcoma cultures, the IHH remained
unchanged at large. IHH can be a good candidate gene to be taken in consideration for future
studies. Additionally, the process of chondrocyte differentiation and maturation is a complex one
that involves many pathways that often intertwine with each another, not limited to: wingless-int
family members (wnts), fibroblast growth factors (FGFs), insulin-like growth factors (IGFs) and
hormone molecules such as: androgen, estrogen and glucocorticoids.
SOX9 – In the primary (CON5) chondrocyte, the narrative that merged from our relative
gene expression results indicate that SOX9 is mainly sensitive to acidosis and independent from
hypoxia. The synergistic effect of hypoxia and acidosis is mainly driven by acidosis alone since
hypoxia by itself induced slight downregulation (-0.74 ± 0.0889 SEM), acidosis had the most
profound effect (2.60 ± 0.09 SEM) and the combined stressors induced upregulation (2.36 ±
0.085 SEM) (Fig. 12). This is consistent with published data from other sources (Das, et al.,
2009). However, there are conflicting reports in the published literature on SOX9 expression in
cartilage. Some report downregulation (Gebauer, et al., 2005) some report both up- and
downregulation dependent on exposure time to acidosis (Das, et al., 2009). SOX9 plays a crucial
role in chondrogenesis and has direct control on a multitude of genes involved in ECM secretion,
not limited to COL2A1, COL10A1, and ACAN. The latter ones establish a predominant
hypocellular homeostatic environment with ample matrix secretion. In addition, SOX9 induces
mesenchymal stem cells to differentiate into chondrocytes, and once they have differentiated it
delays their eventual hypertrophy (Akiyama, Chaboissier, Martin, Schedl, & de Crombrugghe,
2002).
In chondrosarcoma cells, SOX9 expression was at large either downregulated in most
conditions or experienced no significant difference from the control (Table 6). This is in line
with published research. For example, Tang, et al. (2010) showed that SW1353 display low
SOX9 and Col2A1 expression, and those levels are reversed in dedifferentiated chondrosarcoma.
It might seem counterintuitive considering that SOX9 delays chondrocyte hypertrophy, but this
points to the direction that the carcinogenesis of these chondrosarcoma does not lie with SOX9
mutation but with some other genes. In our case, IDH1/IDH2 are potential frontrunners. From a
scientific standpoint this is supported due to the increased hypercellularity, especially in JJ012.
Chondrosarcoma cells, particularly grade II and III direct much of their metabolic energy not at
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producing ECM but rather multiplying, so SOX9 expression is not as essential to their expansion
and evasive nature. A question that stands is: What causes SOX9 to be significantly
downregulated in chondrosarcoma (p<0.001) in comparison to healthy cartilage in combined
conditions? This leads us to IDH1/IDH2 analysis.
IDH1/IDH2 - Nakagawa, et al. (2019) showed that once the IDH1 mutant was inhibited
by DS-1001b inhibitor in grade III chondrosarcoma, the SOX9 expression went back up. This can
elucidate why SOX9 levels were depressed in the chondrosarcomas. However, the mechanism by
which it does so needs further investigation and is a good direction for future studies. JJ012
heterozygous IDH1 mutation is somatic in origin in the R132G allele region via (CGT>GGT)
missense mutation while SW1353 harbor IDH2 gene mutation in the R172S region (Suijker,
2015). Indeed, our results showed that IDH1 was upregulated in the combined condition in JJ012
(1.19 ± 0.31 SEM). (Fig. 13). The expression was significant compared to SW1353 (p<0.001)
and to CON5 (p<0.01) (Table 3). This further highlights the conclusion that JJ012 is sensitive to
both these stressors due to the IDH1 mutation that it harbors. Interestingly, acidosis and hypoxia
on their own had opposite effects, with the former downregulating it (-0.83 ± 0.29 SEM) and the
later upregulating it (0.50 ± 0.18 SEM). Additionally, D-2-HG concentration levels in JJ012 cell
lysate were significantly more elevated (p<0.001) or 10.5-fold higher when compared to that of
CON5 (Table 5). Lastly, SW1353 and CON5 expressed no meaningful difference in any of the
conditions compared to the control since they are not IDH1 mutants.
Our expectation for IDH2 expression was that it was going to be significantly more
upregulated in SW1353 when compared with the other two cell lines. Our results indicate that
IDH2 is heavily driven by acidosis and that is observable in all three cell lines (Fig. 14). The key
data that helped to elucidate the acidosis dependent relationship was derived by the gene
expression in CON5. Hypoxia slightly downregulated the expression (-0.46 ± 0.0781 SEM);
acidosis significantly upregulated it (2.02 ± 0.0984 SEM) and their combined effect resulted in
upregulation (1.58 ± 0.1495 SEM). In some ways it was irrelevant whether a cell line was an
IDH2 mutant or a wild type because they were all induced by acidosis.
IDH1/IDH2 expression were expected to be elevated in JJ012 and SW1353 but the
question that emerged from our gene expression data is: why does IDH wild type CON5 show
elevated expression of IDH2 expression in acidosis? Especially since the D-2-HG concentration
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levels in CON5 were 10.5-fold and 6-fold lower than those of JJ012 and SW1353 respectively.
As described in the procedure, the cell lysate used to measure the D-2-HG were obtained from
cells that were grown in normoxia/pH=7. The D-2-HG concentration levels produced in hypoxia
and acidosis were not measured. This would be an excellent direction and quantifiable data point
to further support the gene expression data. Indeed, there is some evidence that indirectly
supports the idea that acidosis induces decreased levels of α-KG. Intlekofer, et al. (2017) showed
that in response to acidosis (pH=6.0, similar to what hypoxic cells experience), L-2-HG was
elevated, and α-KG was reduced by about four-fold. To my knowledge, D-2-HG has not been
tested under acidic condition. However, D/L-2-HG are chiral (enantiomer) molecules with
similar function to inhibit α-KG. One would expect elevated D-2-HG and downregulated α-KG
levels in acidosis just like the ones recorded for L-2-HG.
Hypoxia/Acidosis – From our gene data, we can conclude that inducible hypoxia and
extracellular acidosis play a significant role in altering gene expression in all three cell lines
under investigation whether individually or combined. Our experiment design included two
chondrosarcoma grade II and one primary chondrocyte cell line grown in four experimental
conditions: hypoxia (5% oxygen), acidosis(pH=5.5), normoxia/pH=7.0 and hypoxia/acidosis.
For future experiment designs, I would suggest that instead of having one fixed pH of acidosis to
incorporate a pH range. For example, pH from 6.0-7.0 divided into increments of 0.2. Moreover,
to develop a better understanding of the effects of hypoxia, cells can be grown in 1% oxygen in
addition to the 5% and 21% oxygen levels. As previously discussed, chondrocytes are exposed to
an oxygen gradient that changes in deeper layers of cartilage. 5% oxygen inducible hypoxia used
in our study can be applicable more to the resting chondrocytes but not mirror the oxygen
exposure in cells found in deeper cartilage layers such as in the proliferating and hypertrophic
zones. This would provide further data to build a comprehensive comparison between
experimental conditions, cells, and genes of interest.
In our study, the three samples represent three distinct age groups. CON5 –female, mid
20s; JJ012 – male, late 30s; and SW1353 – female, early 70s. We know that age plays an
important role in chondrosarcoma. The predominant number of cases are reported between the
ages of 30 and 60 at a 1:1,000,000 incidence. However, the age of the third group (70+) are even
more susceptible to develop it (Hogendoorn, et al., 2010). Chondrogenesis is a highly regulated
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process by many sex hormones not limited to PTHrP, the female hormones of estrogen and
progesterone, and the male hormone androgen. As we age, these hormone steroid levels can
deplete or be imbalanced for a multitude of reasons, exposing cartilage to many possible diseases
including chondrosarcoma and osteoarthritis (Wolff, et al., 2012). Such steroids can affect SOX9
levels which are crucial at birth for normal cartilage development (Mork, 2010). But as we stop
growing and continue to age, those levels can be at risk of being downregulated and induce
cartilage frailties. Since SW1353 was isolated from a 72-year-old woman, that can possibly
introduce a new confounding factor. However, a larger pool sample of cells from a variety of age
groups would be required to elucidate that relationship.
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CHAPTER 5
CONCLUSION
Inducible hypoxia and extracellular acidosis play a significant role in gene expression in
cartilage biology. This is true due to the hypoxic (5%-1% oxygen) and slightly acidic
environment in which chondrocytes reside. Four genes of interest were analyzed. On one side,
PTHR1 and SOX9 were considered. They are known to delay chondrocyte differentiation while
delaying their hypertrophy. PTHR1 is involved in the PTHrP-IHH loop and is induced by HIF1α. On the other side, IDH1 and IDH2 were chosen for relative gene analysis since they are
crucial metabolic enzymes that convert isocitrate into α-ketoglutarate in the TCA cycle. Since
IDH1/IDH2 have been reported to mutate in cancer cells, two chondrosarcoma grade II cell lines
JJ012 and SW1353 were chosen in addition to one IDH wildtype primary chondrocyte – CON5.
The grade characterization was described for each cell line and morphological differences
defined. The presence of IDH1/IDH2 mutations in the chondrosarcomas was further supported
by measuring the D-2- Hydroxyglutarate concentration levels in all three cells lines. D-2-HG
levels were 10.5-fold (JJ012) and 6-fold (SW1353) higher than in CON5. The effects of acidosis
on D-2-HG should be further investigated since our colorimetric assay was conducted in
normoxia/pH=7. Our results indicate that IDH2 is sensitive to acidosis in all three cell lines
analyzed. Similarly, SOX9 is acidosis dependent and it is most upregulated in primary
chondrocyte (2.60 ± 0.09 SEM). Our data showed that the only cell line under which PTHR1 was
consistently upregulated in all three conditions was in primary chondrocyte: hypoxia/acidosis
(2.10± 0.835 SEM); hypoxia (1.29 ± 0.04) and acidosis (0.84 ± 0.03). The PTHR1 expression
was not as elevated in chondrosarcoma as we expected it to be. This indicates that PTHR1 is
largely missing and other aspects of PTHrP -IHH loop or other signaling pathway need to be
analyzed.
These results show that these stressors alternate gene expression when individually
applied as well as combined, re-emphasizing the importance of including them in cartilage
research. Their synergistic effect can be further elucidated by incorporating a wider range of pH
and oxygen levels.
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